CAS: 83200-10-6; 2-(3-Methoxyphenyl)-2-[3-[2-(3-Methoxyphenyl)Ethyl-Methylamino]Propyl]Tetradecanenitrile

该化合物是属于被称为钙通道阻塞器的一类药剂的化学化合物,其主要特征是它能够抑制通过电压加热的钙渠道输送的钙离子,这种渠道在包括肌肉收缩和...

结构式图片

MSDS等安全信息

    上下游产品

    3-methoxyphenylacetonitrile 1-dodecyl alcohol 2-(3-methoxyphenyl)-N-methylethan-1-amine α-dodecyl-3-methoxybenzylcyanide

    合成工艺路线路线简述

      📜Alpha-十二烷基-3-甲氧基-苯乙腈置于三溴化磷,Potassium Carbonate,C30H28Brmnno2P2体系中,用 甲苯 作为反应溶剂,化学反应 12.5H,反应生成 阿尼帕米
      参考文献:锰催化烯丙醇和腈的交叉偶联:获得 δ-羟基腈的优雅途径
      标题:锰催化烯丙醇和腈的交叉偶联:获得 δ-羟基腈的优雅途径
      摘要:醇和腈衍生物是非常重要的骨架,广泛应用于有机和生物有机化学.由于其 100% 的原子经济性和易于获得的起始材料,通过形式共轭加成的醇和腈的交叉偶联是获得长碳链束缚腈的强大且环境友好的策略.在此,我们报道了钳形锰 (I) 催化腈与烯丙醇的氧化还原中性偶联以形成各种 δ-羟基腈的第一个例子.该反应在简单条件下具有广泛的底物范围和非常好的官能团耐受性(43 个例子,50-94% 产率).值得注意的是,阿尼帕米和维拉帕米的成功合成进一步证明了该协议的温和性和实用性通过一个或两个级联借氢程序.
      DOI:10.1039/d2Gc03679G

      海关参考信息

      专利信息


      专利号:US-2008287407-A1
      优先权日:2003-12-10
      标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
      发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
      权利人:NITROMED INC
      摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

      专利号:US-8487108-B2
      优先权日:2005-11-14
      标题 :Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors
      发明人:BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T
      权利人:BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T; VITAE PHARMACEUTICALS INC
      摘要:The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.

      专利号:WO-2006097348-A1
      优先权日:2005-03-15
      标 题:Use of agents such as nonpolymeric nitric oxide donors for making the lips full again and/or colouring the lips
      发明人:CALS-GRIERSON MARIE-MADELEINE
      权利人:OREAL; CALS-GRIERSON MARIE-MADELEINE
      摘要:The invention relates in particular to the cosmetic use (i) of at least one agent for promoting the production of NO in and/or on the lips, chosen from nitric oxide NO donors or precursors; nonpolymeric NO releasers; and NO synthase synthesis and/or activity stimulators; or (ii) of other agents for promoting microcirculation in the skin, chosen from potassium channel openers; calcium channel blockers; phosphodiesterase inhibitors; flavonoids; vasodilator peptides that are not NO donors; temperature modulators; agents for promoting the stimulation and/or maintenance of angiogenesis; agents for promoting the stimulation of endothelial cell proliferation; agents for promoting endothelial cell migration; and mixtures thereof, in a makeup and/or care composition for the lips, as an agent for naturally making the lips full again and/or naturally coloring the lips. It also relates to specific care and/or makeup compositions for the lips containing said agent, and also to a cosmetic process aimed at making the lips naturally full and/or colored, using said compositions .

      专利号:TW-201518323-A
      优先权日:2013-07-25
      标题 :Synthesis of biological conjugates of APELIN polypeptides

      专利号:EA-014940-B1
      优先权日:2005-08-25
      标题 :Condensed Derivatives of Imidazole to Inhibit Aldosterone Synthesis and Aromatics

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Pugsley MK, Ries CR, Guppy LJ, Harvie CJ, Walker MJ. Effects of anipamil, a long acting analog of verapamil, in pigs subjected to myocardial ischemia. Life Sci. 1995;57(12):1219-31.

      合成参考文献


      摘要:Ciplea AG, Kretzschmar R, Heimann W, Kirchengast M, Safer A. Protective effect of the new calcium antagonist anipamil against isoprenaline-induced cardionecrosis in rats. Arzneimittelforschung. 1988 Feb;38(2):215–21.
      参考文献:10.1097/00005344-198712000-00012
      摘要:Panagiotopoulos S, Nayler WG. Nicotine-Induced Calcium Overload During Postischemic Reperfusion. Journal of Cardiovascular Pharmacology. 1987 Dec;10(6):683–91. doi: 10.1097/00005344-198712000-00012.
      参考文献:10.1007/bf00877727
      摘要:Larsen CT, Sørum C, Rasmussen V, Fischer Hansen J. Anipamil prevents ST depression in patients with stable angina pectoris. Cardiovasc Drugs Ther. 1993 Dec;7(6):915–21. doi: 10.1007/bf00877727.
      参考文献:10.1007/bf00173549
      摘要:Raddino R, Poli E, Pasini E, Ferrari R. Effects of the novel calcium channel blocker, anipamil, on the isolated rabbit heart. Comparison with verapamil and gallopamil. Naunyn Schmiedebergs Arch Pharmacol. 1992 Sep;346(3):339–44. doi: 10.1007/bf00173549.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知